From HDACi to KDACi: we need to revisit non-epigenetic pathways affected by inhibiting lysine deacetylases in therapy

Abstract

Lysine deacetylases act on many other proteins apart from histones, with effects on metabolism and gene expression. We need to be cautious that therapeutically used KDACi have a much more widespread impact than anticipated.